We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Amiodarone and cyclophosphamide: potential for enhanced lung toxicity.
- Authors
Bhagat, R; Sporn, T A; Long, G D; Folz, R J
- Abstract
Antineoplastic therapy can be associated with drug-induced lung toxicity. With the increasing use of amiodarone for cardiac dysrhythmias there is an increasing possibility of its combined use with chemotherapies for various malignancies. We report a patient on long-term amiodarone who developed biopsy-proven drug-induced lung toxicity after receiving high-dose cyclophosphamide, at a time-frame much shorter than would have been predicted with cyclophosphamide alone. The potential for enhanced lung toxicity secondary to combination of amiodarone and cyclophosphamide is discussed. Bone Marrow Transplantation (2001) 27, 1109–1111.
- Subjects
AMIODARONE; ANTINEOPLASTIC agents
- Publication
Bone Marrow Transplantation, 2001, Vol 27, Issue 10, p1109
- ISSN
0268-3369
- Publication type
Article
- DOI
10.1038/sj.bmt.1703039